Myocardial perfusion abnormality in the area of ventricular septum-free wall junction and cardiovascular events in nonobstructive hypertrophic cardiomyopathy

International Journal of Cardiovascular Imaging

Volumn 28, Issue 7, 2012, Pages 1829-1839

  Kaimoto, Satoshi ^a,b   Kawasaki, Tatsuya ^a   Kuribayashi, Toshiro ^c   Yamano, Michiyo ^a,b   Miki, Shigeyuki ^a   Kamitani, Tadaaki ^a   Matsubara, Hiroaki ^b  

^a MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY   (Japan)

^c Kuribayashi Clinic of Cardiology   (Japan)

Author keywords

Area of junction; Cardiovascular events; Fibrosis; Hypertrophic cardiomyopathy; Myocardial perfusion; Scintigraphy

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; EXERCISE TEST; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; MYOCARDIAL PERFUSION ABNORMALITY; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; REST; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH;

ADULT; AGED; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC; CHI-SQUARE DISTRIBUTION; CORONARY CIRCULATION; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL PERFUSION IMAGING; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STROKE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR SEPTUM;

EID: 84870423409     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-011-9994-z     Document Type: Article

References (28)

1. O'Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach SL, Larson SM, Epstein SE (1987) Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy. Circulation 76:1214-1223.
2. Cannon RO III, Dilsizian V, O'Gara PT, Udelson JE, Schenke WH, Quyyumi A, Fananapazir L, Bonow RO (1991) Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 83:1660-1667.
3. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L (1993) Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 22:796-804. (Pubitemid 23256942)
4. Sorajja P, Chareonthaitawee P, Ommen SR, Miller TD, Hodge DO, Gibbons RJ (2006) Prognostic utility of singlephoton emission computed tomography in adult patients with hypertrophic cardiomyopathy. Am Heart J 151:426-435. (Pubitemid 43144746)
5. Sugihara H, Shiga K, Umamoto I, Harada Y, Katahira T, Nakagawa T, Matsubara K, Nakamura T, Terashima S, Azuma A, Furukawa K, Asayama J, Katsume H, Nakagawa M (1990) Assessment of transient dilation of the left ventricular cavity in patients with hypertrophic cardiomyopathy by exercise thallium-201 scintigraphy. Kaku Igaku 27: 1281-1289.
6. Yoshida N, Ikeda H, Wada T, Matsumoto A, Maki S, Muro A, Shibata A, Imaizumi T (1998) Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 32:1938-1942. (Pubitemid 29010458)
7. Kawasaki T, Azuma A, Kuribayashi T, Taniguchi T, Miyai N, Kamitani T, Kawasaki S, Matsubara H, Sugihara H (2006) Resting ST-segment depression predicts exerciseinduced subendocardial ischemia in patients with hypertrophic cardiomyopathy. Int J Cardiol 107:267-274. (Pubitemid 43075244)
8. Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH (1981) Left ventricular fibre architecture in man. Br Heart J 45:248-263. (Pubitemid 11137851)
9. Kuribayashi T, Furukawa K, Katsume H, Ijichi H, Ibata Y (1986) Regional differences of myocyte hypertrophy and three-dimensional deformation of the heart. Am J Physiol 250:H378-H388.
10. Kuribayashi T, Roberts WC (1992) Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 70:1333-1340.
11. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156-2164. (Pubitemid 36005903)
12. Rudolph A, Abdel-Aty H, Bohl S, Boyé P, Zagrosek A, Dietz R, Schulz-Menger J (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53:284-291.
13. Ohtsuki K, Sugihara H, Kuribayashi T, Nakagawa M(1999) Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. J Nucl Med 40:2007-2013. (Pubitemid 30022014)
14. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, American Heart Association Writing Group on Myocardial Segmentation, Registration for Cardiac Imaging (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539-542. (Pubitemid 34262671)
15. Nakamura T, Sakamoto K, Yamano T, Kikkawa M, Zen K, Hikosaka T, Kubota T, Azuma A, Nishimura T (2002) Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 39:1657-1663. (Pubitemid 34494290)
16. Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, Graham KJ, Burton DA, Cecchi F (2000) Epidemiology of hypertrophic cardiomyopathy- related death: revisited in a large non-referral-based patient population. Circulation 102:858-864.
17. Udelson JE, Dilsizian V, Bonow RO (2007) Nuclear cardiology. In: Libby P, Bonow RO, Mann DL, Zipes DP (eds) Braunwald's heart disease: a textbook of cardiovascular medicine, 8th edn. WB Saunders, Missouri, pp 345-391.
18. Bartlett ML, Bacharach SL, Voipio-Pulkki LM, Dilsizian V (1995) Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects. J Nucl Med 36:188-195.
19. Li ST, Tack CJ, Fananapazir L, Goldstein DS (2000) Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 35:1867-1873. (Pubitemid 30342869)
20. Germano G, Chua T, Kiat H, Areeda JS, Berman DS (1994) A quantitative phantom analysis of artifacts due to hepatic activity in technetium-99m myocardial perfusion SPECT studies. J Nucl Med 35:356-359. (Pubitemid 24048327)
21. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, Nassenstein K, Schlosser T, Sabin GV, Sechtem U, Mahrholdt H (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56:875-887.
22. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867-874.
23. Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ (2010) Characteristics and clinical significance of late gadolinium enhancement by contrastenhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 3:51-58.
24. Kawasaki T, Yamano M, Kuribayashi T, Kaimoto S, Miki S, Kamitani T, Matsubara H, Sugihara H (2011) Three-layer ultrasonic tissue characterization of the ventricular septum is predictive of prognosis in patients with non-obstructive hypertrophic cardiomyopathy. Eur J Echocardiogr 12: 90-97.
25. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ (2004) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43:2260-2264. (Pubitemid 38757595)
26. Phillips CA, Grood ES, Schuster B, Petrofsky JS (1982) Left ventricular work and power: circumferential, radial and longitudinal components. Mathematical derivation and characteristic variation with left ventricular dysfunction. J Biomech 15:427-440. (Pubitemid 12038726)
27. Kuribayashi T, Mizuta T, Shimoo K, Kubota Y, Katsume H, Nakagawa M, Ibata Y (1988) Spontaneously occurring hypertrophic cardiomyopathy in the rat. II. Distribution of, and correlations between, various cardiac abnormalities in the WKY/NCrj and its related strains. Jpn Circ J 52: 1156-1170. (Pubitemid 19019387)
28. Kuribayashi T, Shimoo K, Nakamura T, Hamaoka K, Nakagawa M, Ibata Y, Mizuta T, Komeda T, Nagaoka A (1990) Tetralogy of Fallot, cardiac hypertrophy, pulmonary hypertension, and anomalies of great vessels in fetuses and neonates of WKY/NCrj rats. Pediatr Res 28:429-436. (Pubitemid 20366684)